Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia
  • The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study

    Journal of Human Hypertension Date published:
  • Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities

    JAMA Network Open Date published:
  • Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

    Circulation Date published:
  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial

    Kidney International Reports Date published:
  • Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

    International Journal of Cardiology Date published:
  • Switching the World’s Salt Supply-Learning from Iodization to Achieve Potassium Enrichment

    Advances in Nutrition Date published:
  • Criterion validation of nutrient profiling systems: a systematic review and meta-analysis

    The American Journal of Clinical Nutrition Date published:
  • Factors influencing the time to ethics and governance approvals for clinical trials: a retrospective cross-sectional survey

    Trials Date published:
  • A novel approach to estimate product-specific greenhouse gas emissions for 23,550 Australian packaged foods and beverages

    Journal of Cleaner Production Date published:
  • Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes

    Kidney International Date published:
  • Protocol for a randomized controlled trial of medically tailored meals compared to usual care among individuals with type 2 diabetes in Australia

    Contemporary Clinical Trials Date published:
  • Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality

    European Heart Journal Date published:
  • Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial

    Circulation Date published:
  • Food is medicine: pilot testing a 'Produce Prescription' program in Australia

    Date published:
  • Delays between clinical trial evidence availability and guideline recommendations: a temporal analysis in the area of blood pressure lowering

    Cardiovascular prevention through improved blood pressure and cholesterol lowering Date published:
  • Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia

    European Journal of Nutrition Date published: